Picture Berlin Partner Events Bionnale 2025 May HealthCapital 650x100px

Document › Details

Centogene N.V.. (5/15/24). "Press Release: Centogene Reports Full Year 2023 Financial Results and Recent Business Highlights". Cambridge, MA, Rostock & Berlin.

	Organisation	Centogene N.V. (OTCOX: CNTGF)
	Group	Centogene (Group)
	Organisation 2	Lifera (SA)
	Group	Lifera (Group)
	Product	Centogene Biodatabank
	Product 2	DNA testing services
	Person	Stratton, Kim (Centogene 202202– CEO before Orphazyme + Shire Pharmaceuticals + Novartis)
	Person 2	Coego Rios, Miguel (Centogene 202206– CFO joined as EVP Finance + Legal in 2/22 before Orphazyme + Mundipharma + Shire)

Original document
accessed by [iito] on 2024-11-21

Record changed: 2024-12-09

Picture Informa Connect BioProcess Intl Europe 2025 Hamburg Register 650x100px

More documents for Centogene (Group)

[1] Centogene N.V.. (3/12/25). "Press Release: Centogene Closes Strategic Transaction with Private Equity Group Charme Capital Partners". Cambridge, MA, Rostock & Berlin....
[2] Centogene N.V.. (11/13/24). "Press Release: Centogene Signs Strategic Transaction with Private Equity Group Charme Capital Partners [not for release, publication or distribution, where unlawful]". Cambridge, MA & Rostock....
[3] Centogene N.V.. (8/7/24). "Press Release: Centogene Receives Delisting Notice From Nasdaq". Cambridge, MA, Rostock & Berlin....
[4] Centogene N.V.. (6/20/24). "Press Release: C-Path and Centogene MOU to Enhance Collaboration in Lysosomal Disease Research and Drug Development". Tucson, AZ, Cambridge, MA & Rostock....
[5] Centogene N.V.. (5/15/24). "Press Release: Centogene Secures Approx. $20 Million to Strengthen Cash Position. Expanding Relationship With Lifera, a Biopharma Company Owned by the PIF". Cambridge, MA, Rostock & Berlin....
[6] Centogene N.V.. (5/14/24). "Press Release: Centogene and Evotec Discover Promising New Molecule to Treat Gaucher Disease". Cambridge, MA, Rostock & Berlin....
[7] Centogene N.V.. (2/28/24). "Press Release: Centogene Announces Receipt of Nasdaq Notice of Delisting and Intention to Request a Hearing". Cambridge, MA, Rostock & Berlin....
[8] Centogene N.V.. (2/28/24). "Press Release: Centogene Explores Strategic Alternatives". Cambridge, MA, Rostock & Berlin....
[9] Centogene N.V.. (11/28/23). "Press Release: Centogene and Lifera, a Public Investment Fund (PIF) Company, Complete Strategic Joint Venture Transaction". Cambridge, MA, Rostock & Berlin....
[10] Centogene N.V.. (6/27/23). "Press Release: Centogene and Lifera, a Biopharma Company Owned by the PIF, Enter Strategic Collaboration – Forming Saudi Arabian Joint Venture to Increase Access to Leading Data-Driven Multiomic Testing and Securing CENTOGENE...

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)